Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

McKinnell JA, Dwyer JP, Talbot GH, Connolly LE, Friedland I, Smith A, Jubb AM, Serio AW, Krause KM, Daikos GL; CARE Study Group.

N Engl J Med. 2019 Feb 21;380(8):791-793. doi: 10.1056/NEJMc1807634. No abstract available.

PMID:
30786196
2.

Accuracy of methods for reporting inorganic element concentrations and radioactivity in oil and gas wastewaters from the Appalachian Basin, U.S. based on an inter-laboratory comparison.

Tasker TL, Burgos WD, Ajemigbitse MA, Lauer NE, Gusa AV, Kuatbek M, May D, Landis JD, Alessi DS, Johnsen AM, Kaste JM, Headrick KL, Wilke FDH, McNeal M, Engle M, Jubb AM, Vidic RD, Vengosh A, Warner NR.

Environ Sci Process Impacts. 2019 Feb 21;21(2):224-241. doi: 10.1039/c8em00359a.

PMID:
30452047
3.

Characterization of iron oxide nanoparticle films at the air-water interface in Arctic tundra waters.

Jubb AM, Eskelsen JR, Yin X, Zheng J, Philben MJ, Pierce EM, Graham DE, Wullschleger SD, Gu B.

Sci Total Environ. 2018 Aug 15;633:1460-1468. doi: 10.1016/j.scitotenv.2018.03.332. Epub 2018 Apr 4.

PMID:
29758898
4.

Photochemical reactions between mercury (Hg) and dissolved organic matter decrease Hg bioavailability and methylation.

Luo HW, Yin X, Jubb AM, Chen H, Lu X, Zhang W, Lin H, Yu HQ, Liang L, Sheng GP, Gu B.

Environ Pollut. 2017 Jan;220(Pt B):1359-1365. doi: 10.1016/j.envpol.2016.10.099. Epub 2016 Nov 9.

PMID:
27836473
5.

Mercury-Pollution Induction of Intracellular Lipid Accumulation and Lysosomal Compartment Amplification in the Benthic Foraminifer Ammonia parkinsoniana.

Frontalini F, Curzi D, Cesarini E, Canonico B, Giordano FM, De Matteis R, Bernhard JM, Pieretti N, Gu B, Eskelsen JR, Jubb AM, Zhao L, Pierce EM, Gobbi P, Papa S, Coccioni R.

PLoS One. 2016 Sep 7;11(9):e0162401. doi: 10.1371/journal.pone.0162401. eCollection 2016.

6.

Elevated gold ellipse nanoantenna dimers as sensitive and tunable surface enhanced Raman spectroscopy substrates.

Jubb AM, Jiao Y, Eres G, Retterer ST, Gu B.

Nanoscale. 2016 Mar 14;8(10):5641-8. doi: 10.1039/c5nr08920d.

PMID:
26893035
7.

Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.

Ong CC, Gierke S, Pitt C, Sagolla M, Cheng CK, Zhou W, Jubb AM, Strickland L, Schmidt M, Duron SG, Campbell DA, Zheng W, Dehdashti S, Shen M, Yang N, Behnke ML, Huang W, McKew JC, Chernoff J, Forrest WF, Haverty PM, Chin SF, Rakha EA, Green AR, Ellis IO, Caldas C, O'Brien T, Friedman LS, Koeppen H, Rudolph J, Hoeflich KP.

Breast Cancer Res. 2015 Apr 23;17:59. doi: 10.1186/s13058-015-0564-5.

8.

Effect of selective LRRK2 kinase inhibition on nonhuman primate lung.

Fuji RN, Flagella M, Baca M, Baptista MA, Brodbeck J, Chan BK, Fiske BK, Honigberg L, Jubb AM, Katavolos P, Lee DW, Lewin-Koh SC, Lin T, Liu X, Liu S, Lyssikatos JP, O'Mahony J, Reichelt M, Roose-Girma M, Sheng Z, Sherer T, Smith A, Solon M, Sweeney ZK, Tarrant J, Urkowitz A, Warming S, Yaylaoglu M, Zhang S, Zhu H, Estrada AA, Watts RJ.

Sci Transl Med. 2015 Feb 4;7(273):273ra15. doi: 10.1126/scitranslmed.aaa3634.

PMID:
25653221
9.

PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.

Zhou W, Jubb AM, Lyle K, Xiao Q, Ong CC, Desai R, Fu L, Gnad F, Song Q, Haverty PM, Aust D, Grützmann R, Romero M, Totpal K, Neve RM, Yan Y, Forrest WF, Wang Y, Raja R, Pilarsky C, de Jesus-Acosta A, Belvin M, Friedman LS, Merchant M, Jaffee EM, Zheng L, Koeppen H, Hoeflich KP.

J Pathol. 2014 Dec;234(4):502-13. doi: 10.1002/path.4412. Epub 2014 Oct 6.

10.

A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.

Kallop DY, Meilandt WJ, Gogineni A, Easley-Neal C, Wu T, Jubb AM, Yaylaoglu M, Shamloo M, Tessier-Lavigne M, Scearce-Levie K, Weimer RM.

J Neurosci. 2014 May 7;34(19):6425-37. doi: 10.1523/JNEUROSCI.4963-13.2014.

11.

Methyl-perfluoroheptene-ethers (CH3OC7F13): measured OH radical reaction rate coefficients for several isomers and enantiomers and their atmospheric lifetimes and global warming potentials.

Jubb AM, Gierczak T, Baasandorj M, Waterland RL, Burkholder JB.

Environ Sci Technol. 2014 May 6;48(9):4954-62. doi: 10.1021/es500888v. Epub 2014 Apr 14.

PMID:
24702168
12.

Lymph node-independent liver metastasis in a model of metastatic colorectal cancer.

Enquist IB, Good Z, Jubb AM, Fuh G, Wang X, Junttila MR, Jackson EL, Leong KG.

Nat Commun. 2014 Mar 26;5:3530. doi: 10.1038/ncomms4530.

PMID:
24667486
13.

DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid.

MacFie TS, Poulsom R, Parker A, Warnes G, Boitsova T, Nijhuis A, Suraweera N, Poehlmann A, Szary J, Feakins R, Jeffery R, Harper RW, Jubb AM, Lindsay JO, Silver A.

Inflamm Bowel Dis. 2014 Mar;20(3):514-24. doi: 10.1097/01.MIB.0000442012.45038.0e. Erratum in: Inflamm Bowel Dis. 2014 Apr;20(4):775.

PMID:
24492313
14.

Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration.

Pozniak CD, Sengupta Ghosh A, Gogineni A, Hanson JE, Lee SH, Larson JL, Solanoy H, Bustos D, Li H, Ngu H, Jubb AM, Ayalon G, Wu J, Scearce-Levie K, Zhou Q, Weimer RM, Kirkpatrick DS, Lewcock JW.

J Exp Med. 2013 Nov 18;210(12):2553-67. doi: 10.1084/jem.20122832. Epub 2013 Oct 28.

15.

Pathology in drug discovery and development.

Jubb AM, Koeppen H, Reis-Filho JS.

J Pathol. 2014 Jan;232(2):99-102. doi: 10.1002/path.4290.

PMID:
24122335
16.

1,2-Dichlorohexafluoro-cyclobutane (1,2-c-C4F6Cl2, R-316c) a potent ozone depleting substance and greenhouse gas: atmospheric loss processes, lifetimes, and ozone depletion and global warming potentials for the (E) and (Z) stereoisomers.

Papadimitriou VC, McGillen MR, Smith SC, Jubb AM, Portmann RW, Hall BD, Fleming EL, Jackman CH, Burkholder JB.

J Phys Chem A. 2013 Oct 31;117(43):11049-65. doi: 10.1021/jp407823k. Epub 2013 Oct 17.

PMID:
24079521
17.

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.

Johnson L, Huseni M, Smyczek T, Lima A, Yeung S, Cheng JH, Molina R, Kan D, De Mazière A, Klumperman J, Kasman I, Zhang Y, Dennis MS, Eastham-Anderson J, Jubb AM, Hwang O, Desai R, Schmidt M, Nannini MA, Barck KH, Carano RA, Forrest WF, Song Q, Chen DS, Naumovski L, Singh M, Ye W, Hegde PS.

J Clin Invest. 2013 Sep;123(9):3997-4009. doi: 10.1172/JCI67892. Epub 2013 Aug 15.

18.

Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.

Jubb AM, Ribas A, Sosman JA, McArthur GA, Yan Y, Rost S, Zhao S, Koeppen H.

Histopathology. 2013 Sep;63(3):351-61. doi: 10.1111/his.12169. Epub 2013 Jun 26.

PMID:
23802768
19.

Sulfate adsorption at the buried hematite/solution interface investigated using total internal reflection (TIR)-Raman spectroscopy.

Jubb AM, Verreault D, Posner R, Criscenti LJ, Katz LE, Allen HC.

J Colloid Interface Sci. 2013 Jun 15;400:140-6. doi: 10.1016/j.jcis.2013.02.031. Epub 2013 Mar 6.

PMID:
23562663
20.

P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.

Ong CC, Jubb AM, Jakubiak D, Zhou W, Rudolph J, Haverty PM, Kowanetz M, Yan Y, Tremayne J, Lisle R, Harris AL, Friedman LS, Belvin M, Middleton MR, Blackwood EM, Koeppen H, Hoeflich KP.

J Natl Cancer Inst. 2013 May 1;105(9):606-7. doi: 10.1093/jnci/djt054. Epub 2013 Mar 27.

PMID:
23535073
21.

High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck.

Shames DS, Carbon J, Walter K, Jubb AM, Kozlowski C, Januario T, Do A, Fu L, Xiao Y, Raja R, Jiang B, Malekafzali A, Stern H, Settleman J, Wilson TR, Hampton GM, Yauch RL, Pirzkall A, Amler LC.

PLoS One. 2013;8(2):e56765. doi: 10.1371/journal.pone.0056765. Epub 2013 Feb 28. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/63f57c72-c869-4ef5-94d1-3cbd6c2e3678. AnDo [corrected to Do, An].

22.

Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab.

Hegde PS, Jubb AM, Chen D, Li NF, Meng YG, Bernaards C, Elliott R, Scherer SJ, Chen DS.

Clin Cancer Res. 2013 Feb 15;19(4):929-37. doi: 10.1158/1078-0432.CCR-12-2535. Epub 2012 Nov 20.

23.

LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance.

Lee SU, Maeda M, Ishikawa Y, Li SM, Wilson A, Jubb AM, Sakurai N, Weng L, Fiorini E, Radtke F, Yan M, Macdonald HR, Chen CC, Maeda T.

Blood. 2013 Feb 7;121(6):918-29. doi: 10.1182/blood-2012-03-418103. Epub 2012 Nov 7.

24.

p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.

Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ, Gutkind JS, Hoeflich KP, Chernoff J.

Cancer Res. 2012 Nov 15;72(22):5966-75. doi: 10.1158/0008-5472.CAN-12-2246. Epub 2012 Sep 14.

25.

Prognostic and predictive significance of proliferation in 867 colorectal cancers.

Fodor IK, Hutchins GG, Espiritu C, Quirke P, Jubb AM.

J Clin Pathol. 2012 Nov;65(11):989-95. doi: 10.1136/jclinpath-2012-200911. Epub 2012 Aug 2.

PMID:
22859394
26.

In situ validation of an intestinal stem cell signature in colorectal cancer.

Ziskin JL, Dunlap D, Yaylaoglu M, Fodor IK, Forrest WF, Patel R, Ge N, Hutchins GG, Pine JK, Quirke P, Koeppen H, Jubb AM.

Gut. 2013 Jul;62(7):1012-23. doi: 10.1136/gutjnl-2011-301195. Epub 2012 May 25.

PMID:
22637696
27.

Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.

Singh M, Couto SS, Forrest WF, Lima A, Cheng JH, Molina R, Long JE, Hamilton P, McNutt A, Kasman I, Nannini MA, Reslan HB, Cao TC, Ho CC, Barck KH, Carano RA, Foreman O, Eastham-Anderson J, Jubb AM, Ferrara N, Johnson L.

J Pathol. 2012 Aug;227(4):417-30. doi: 10.1002/path.4053. Epub 2012 Jun 28.

PMID:
22611036
28.

Neuropilin-2 expression in cancer.

Jubb AM, Sa SM, Ratti N, Strickland LA, Schmidt M, Callahan CA, Koeppen H.

Histopathology. 2012 Sep;61(3):340-9. doi: 10.1111/j.1365-2559.2012.04224.x. Epub 2012 Mar 2.

PMID:
22384800
29.

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.

Jubb AM, Browning L, Campo L, Turley H, Steers G, Thurston G, Harris AL, Ansorge O.

Histopathology. 2012 Apr;60(5):740-7. doi: 10.1111/j.1365-2559.2011.04138.x. Epub 2012 Feb 1.

PMID:
22296176
30.

Environmental chemistry at vapor/water interfaces: insights from vibrational sum frequency generation spectroscopy.

Jubb AM, Hua W, Allen HC.

Annu Rev Phys Chem. 2012;63:107-30. doi: 10.1146/annurev-physchem-032511-143811. Epub 2012 Jan 3. Review.

PMID:
22224702
31.

Organization of water and atmospherically relevant ions and solutes: vibrational sum frequency spectroscopy at the vapor/liquid and liquid/solid interfaces.

Jubb AM, Hua W, Allen HC.

Acc Chem Res. 2012 Jan 17;45(1):110-9. doi: 10.1021/ar200152v. Epub 2011 Nov 8.

PMID:
22066822
32.

Neuropilin-1 expression in cancer and development.

Jubb AM, Strickland LA, Liu SD, Mak J, Schmidt M, Koeppen H.

J Pathol. 2012 Jan;226(1):50-60. doi: 10.1002/path.2989. Epub 2011 Oct 25.

PMID:
22025255
33.

p21-activated kinase 1: PAK'ed with potential.

Ong CC, Jubb AM, Zhou W, Haverty PM, Harris AL, Belvin M, Friedman LS, Koeppen H, Hoeflich KP.

Oncotarget. 2011 Jun;2(6):491-6. Review.

34.

Notch3 signalling promotes tumour growth in colorectal cancer.

Serafin V, Persano L, Moserle L, Esposito G, Ghisi M, Curtarello M, Bonanno L, Masiero M, Ribatti D, Stürzl M, Naschberger E, Croner RS, Jubb AM, Harris AL, Koeppen H, Amadori A, Indraccolo S.

J Pathol. 2011 Aug;224(4):448-60. doi: 10.1002/path.2895. Epub 2011 May 19.

PMID:
21598247
35.

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases.

Jubb AM, Cesario A, Ferguson M, Congedo MT, Gatter KC, Lococo F, Mulè A, Pezzella F.

Br J Cancer. 2011 Jun 7;104(12):1877-81. doi: 10.1038/bjc.2011.147. Epub 2011 May 3.

36.

Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.

Ong CC, Jubb AM, Haverty PM, Zhou W, Tran V, Truong T, Turley H, O'Brien T, Vucic D, Harris AL, Belvin M, Friedman LS, Blackwood EM, Koeppen H, Hoeflich KP.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7177-82. doi: 10.1073/pnas.1103350108. Epub 2011 Apr 11.

37.

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.

Jubb AM, Miller KD, Rugo HS, Harris AL, Chen D, Reimann JD, Cobleigh MA, Schmidt M, Langmuir VK, Hillan KJ, Chen DS, Koeppen H.

Clin Cancer Res. 2011 Jan 15;17(2):372-81. doi: 10.1158/1078-0432.CCR-10-1791. Epub 2011 Jan 11.

38.

Biomarkers to predict the clinical efficacy of bevacizumab in cancer.

Jubb AM, Harris AL.

Lancet Oncol. 2010 Dec;11(12):1172-83. doi: 10.1016/S1470-2045(10)70232-1. Review.

PMID:
21126687
39.

Ascl2 and 11p15.5 amplification in colorectal cancer.

Jubb AM, Hoeflich KP, Haverty PM, Wang J, Koeppen H.

Gut. 2011 Nov;60(11):1606-7; author reply 1607. doi: 10.1136/gut.2010.231746. Epub 2010 Nov 23. No abstract available.

PMID:
21106550
40.

The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.

Yang J, Jubb AM, Pike L, Buffa FM, Turley H, Baban D, Leek R, Gatter KC, Ragoussis J, Harris AL.

Cancer Res. 2010 Aug 15;70(16):6456-66. doi: 10.1158/0008-5472.CAN-10-0413. Epub 2010 Aug 3.

41.

Visceral fat and bevacizumab in metastatic colorectal cancer.

Jubb AM.

Gut. 2010 Oct;59(10):1449-50; author reply 1450. doi: 10.1136/gut.2010.213777. Epub 2010 Jul 21. No abstract available.

PMID:
20650923
42.

Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.

Li JL, Jubb AM, Harris AL.

Future Oncol. 2010 Jul;6(7):1099-103. doi: 10.2217/fon.10.62.

PMID:
20624122
43.

Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer.

Herbst RS, Eckhardt SG, Kurzrock R, Ebbinghaus S, O'Dwyer PJ, Gordon MS, Novotny W, Goldwasser MA, Tohnya TM, Lum BL, Ashkenazi A, Jubb AM, Mendelson DS.

J Clin Oncol. 2010 Jun 10;28(17):2839-46. doi: 10.1200/JCO.2009.25.1991. Epub 2010 May 10.

PMID:
20458040
44.

Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.

Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R, Noguera-Troise I, Gatter KC, Thurston G, Harris AL.

Am J Pathol. 2010 Apr;176(4):2019-28. doi: 10.2353/ajpath.2010.090908. Epub 2010 Feb 18.

45.

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.

Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ, Noguera-Troise I, Pezzella F, Gatter KC, Thurston G, Fox SB, Harris AL.

Br J Cancer. 2009 Nov 17;101(10):1749-57. doi: 10.1038/sj.bjc.6605368. Epub 2009 Oct 20.

46.

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.

Jubb AM, Buffa FM, Harris AL.

J Cell Mol Med. 2010 Jan;14(1-2):18-29. doi: 10.1111/j.1582-4934.2009.00944.x. Epub 2009 Oct 16. Review.

47.

Biomarkers and response to therapy in breast cancer.

Jubb AM.

Clin Cancer Res. 2009 Jan 1;15(1):414; author reply 414-5. doi: 10.1158/1078-0432.CCR-08-2404. No abstract available.

48.

Predicting benefit from anti-angiogenic agents in malignancy.

Jubb AM, Oates AJ, Holden S, Koeppen H.

Nat Rev Cancer. 2006 Aug;6(8):626-35. Epub 2006 Jul 13. Review.

PMID:
16837971
49.

Quantitative in situ hybridization of tissue microarrays.

Jubb AM, Pham TQ, Frantz GD, Peale FV Jr, Hillan KJ.

Methods Mol Biol. 2006;326:255-64. Review.

PMID:
16780208
50.

Audit of influenza vaccination in primary care.

Ashwell GK, Aslam AA, Griffin JL, Horsnell K, Rashid N, Shahzad N, Jubb AM.

Br J Gen Pract. 2006 Jun;56(527):461. No abstract available.

Supplemental Content

Support Center